Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The endosomal Na+-dependent uptake pathways refer to a complex system of transporters and channels, primarily the endosomal sodium-hydrogen exchangers (NHE6 and NHE9) and two-pore channels (TPC1 and TPC2), that regulate the ionic environment and pH of the endocytic pathway. These pathways are essential for the productive uptake of therapeutic molecules such as antisense oligonucleotides (ASOs) and siRNA, facilitating their escape from endosomes into the cytosol. Additionally, these pathways are exploited by several enveloped viruses, including Ebola and SARS-CoV-2, which require specific endosomal Na+ concentrations and pH levels for successful membrane fusion and entry. Pharmacological targeting of these pathways with inhibitors like amiloride or tetrandrine is being investigated as a means to block viral infection or enhance the delivery of nucleic acid drugs. Mutations in the genes encoding these transporters, such as SLC9A6 (NHE6) and SLC9A9 (NHE9), are linked to severe neurological conditions, including Christianson syndrome and autism spectrum disorders, highlighting their critical role in brain development and function. These transporters function by coupling the movement of sodium ions to the efflux of protons, thereby acting as a leak pathway to counter the acidification driven by the V-ATPase. This regulation is vital for maintaining the proper timing of endosomal maturation and the sorting of receptors back to the cell surface. In the brain, these pathways influence synaptic plasticity and neurotransmitter transporter recycling, making them key players in cognitive health. Therapeutic challenges include achieving specificity for endosomal isoforms over plasma membrane exchangers to avoid systemic toxicity. Overall, these pathways represent a frontier in both drug delivery optimization and the treatment of rare genetic and infectious diseases.
Inhibition of endosomal Na+/H+ exchange or Na+ channel activity to disrupt viral entry or modulate cargo trafficking.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endosomal sodium-dependent uptake pathway.